<VariationArchive VariationID="1456664" VariationName="NM_001199107.2(TBC1D24):c.752del (p.Phe251fs)" VariationType="Deletion" Accession="VCV001456664" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2022-03-28" MostRecentSubmission="2024-03-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1454766" VariationID="1456664">
      <GeneList>
        <Gene Symbol="TBC1D24" FullName="TBC1 domain family member 24" GeneID="57465" HGNC_ID="HGNC:29203" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2475127" stop="2505730" display_start="2475127" display_stop="2505730" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2525146" stop="2555733" display_start="2525146" display_stop="2555733" Strand="+" />
          </Location>
          <OMIM>613577</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001199107.2(TBC1D24):c.752del (p.Phe251fs)</Name>
      <CanonicalSPDI>NC_000016.10:2496898:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2496899" stop="2496899" display_start="2496899" display_stop="2496899" variantLength="1" positionVCF="2496898" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2546900" stop="2546900" display_start="2546900" display_stop="2546900" variantLength="1" positionVCF="2546899" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F251fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2496900del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2496900del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2546901del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2546901del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028170.1" sequenceAccession="NG_028170" sequenceVersion="1" change="g.26755del">
            <Expression>NG_028170.1:g.26755del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199107.2" sequenceAccession="NM_001199107" sequenceVersion="2" change="c.752del" MANESelect="true">
            <Expression>NM_001199107.2:c.752del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186036.1" sequenceAccession="NP_001186036" sequenceVersion="1" change="p.Phe251fs">
            <Expression>NP_001186036.1:p.Phe251fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020705.3" sequenceAccession="NM_020705" sequenceVersion="3" change="c.752del">
            <Expression>NM_020705.3:c.752del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065756.1" sequenceAccession="NP_065756" sequenceVersion="1" change="p.Phe251fs">
            <Expression>NP_065756.1:p.Phe251fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199107.1" sequenceAccession="NM_001199107" sequenceVersion="1" change="c.752del">
            <Expression>NM_001199107.1:c.752del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="766769998" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001199107.2(TBC1D24):c.752del (p.Phe251fs) AND multiple conditions" Accession="RCV001951260" Version="3">
        <ClassifiedConditionList TraitSetID="31132">
          <ClassifiedCondition DB="MedGen" ID="C3892048">Autosomal dominant nonsyndromic hearing loss 65</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN236805">Caused by mutation in the TBC1 domain family, member 24</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3463992">Developmental and epileptic encephalopathy, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001199107.2(TBC1D24):c.752del (p.Phe251fs) AND multiple conditions" Accession="RCV003987944" Version="2">
        <ClassifiedConditionList TraitSetID="35330">
          <ClassifiedCondition DB="MedGen" ID="C3892048">Autosomal dominant nonsyndromic hearing loss 65</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2829265">Autosomal recessive nonsyndromic hearing loss 86</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0795934">DOORS syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3809173">Developmental and epileptic encephalopathy, 16</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0917800">Familial infantile myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-23" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-03-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23526554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24291220</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="35330" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial infantile myoclonic epilepsy</ElementValue>
                <XRef ID="MONDO:0011506" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FIME</ElementValue>
                <XRef Type="MIM" ID="605021" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIM</ElementValue>
                <XRef Type="MIM" ID="605021" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17521" />
                <XRef ID="17521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TBC1D24-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="352582" DB="Orphanet" />
              <XRef ID="C0917800" DB="MedGen" />
              <XRef ID="MONDO:0011506" DB="MONDO" />
              <XRef Type="MIM" ID="605021" DB="OMIM" />
            </Trait>
            <Trait ID="16955" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 86</ElementValue>
                <XRef ID="MONDO:0013826" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 86</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNB86</ElementValue>
                <XRef Type="MIM" ID="614617" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22643" />
                <XRef ID="22643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2829265" DB="MedGen" />
              <XRef ID="MONDO:0013826" DB="MONDO" />
              <XRef Type="MIM" ID="614617" DB="OMIM" />
            </Trait>
            <Trait ID="18003" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 16</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 16</ElementValue>
                <XRef ID="MONDO:0014133" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE16</ElementValue>
                <XRef Type="MIM" ID="615338" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15945" />
                <XRef ID="15945" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="293181" DB="Orphanet" />
              <XRef ID="352596" DB="Orphanet" />
              <XRef ID="C3809173" DB="MedGen" />
              <XRef ID="MONDO:0014133" DB="MONDO" />
              <XRef Type="MIM" ID="615338" DB="OMIM" />
            </Trait>
            <Trait ID="4931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness onychodystrophy osteodystrophy and mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Digitorenocerebral syndrome</ElementValue>
                <XRef ID="Digitorenocerebral+Syndrome/2280" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME</ElementValue>
                <XRef Type="MIM" ID="220500" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DRC SYNDROME</ElementValue>
                <XRef Type="MIM" ID="222760" DB="OMIM" />
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRACHYDACTYLY DUE TO ABSENCE OF DISTAL PHALANGES</ElementValue>
                <XRef Type="MIM" ID="222760" DB="OMIM" />
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERONEN SYNDROME</ElementValue>
                <XRef Type="MIM" ID="222760" DB="OMIM" />
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">DOORS syndrome</ElementValue>
                <XRef ID="320448" DB="GeneTests" />
                <XRef ID="MONDO:0009079" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DOORS</ElementValue>
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1685" />
                <XRef ID="1685" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522937" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TBC1D24-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="3231" DB="Orphanet" />
              <XRef ID="79500" DB="Orphanet" />
              <XRef ID="C0795934" DB="MedGen" />
              <XRef ID="MONDO:0009079" DB="MONDO" />
              <XRef Type="MIM" ID="220500" DB="OMIM" />
            </Trait>
            <Trait ID="31927" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nonsyndromic hearing loss 65</ElementValue>
                <XRef ID="MONDO:0014470" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal dominant 65</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNA65</ElementValue>
                <XRef Type="MIM" ID="616044" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18140" />
                <XRef ID="18140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90635" DB="Orphanet" />
              <XRef ID="C3892048" DB="MedGen" />
              <XRef ID="MONDO:0014470" DB="MONDO" />
              <XRef Type="MIM" ID="616044" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31132" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1617" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked infantile spasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">West's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tonic spasms with clustering, arrest of psychomotor development and hypsarrhythmia on EEG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Infantile Spasm Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OHTAHARA SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE SPASM SYNDROME, X-LINKED 1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 1</ElementValue>
                <XRef ID="MONDO:0010632" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ISSX1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DEE1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15298" />
                <XRef ID="15298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332436" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519156" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592989" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529356" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557944" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="C3463992" DB="MedGen" />
              <XRef ID="MONDO:0010632" DB="MONDO" />
              <XRef Type="MIM" ID="308350" DB="OMIM" />
            </Trait>
            <Trait ID="35670" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Caused by mutation in the TBC1 domain family, member 24</ElementValue>
              </Name>
              <XRef ID="CN236805" DB="MedGen" />
            </Trait>
            <Trait ID="31927" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nonsyndromic hearing loss 65</ElementValue>
                <XRef ID="MONDO:0014470" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal dominant 65</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNA65</ElementValue>
                <XRef Type="MIM" ID="616044" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18140" />
                <XRef ID="18140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90635" DB="Orphanet" />
              <XRef ID="C3892048" DB="MedGen" />
              <XRef ID="MONDO:0014470" DB="MONDO" />
              <XRef Type="MIM" ID="616044" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4259180" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="11376357|MedGen:C3809181;C3463992;CN220131" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002243130" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23526554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24291220</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe251Serfs*4) in the TBC1D24 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBC1D24 are known to be pathogenic (PMID: 23526554, 24291220). This variant is present in population databases (rs766769998, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with TBC1D24-related conditions. ClinVar contains an entry for this variant (Variation ID: 1456664). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBC1D24" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.2546900del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="C3809181" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3463992" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN220131" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8982908" SubmissionDate="2024-03-14" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="genomeconnect_31617" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004804544" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="GenomeConnect - Brain Gene Registry" OrgID="508359" OrganizationCategory="patient registry" OrgAbbreviation="GenomeConnect - BGR" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant classified as Pathogenic and reported on 11-10-2022 by Invitae . Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2022-11-10" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">genomeconnect_31617</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2022-10-26" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000118" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBC1D24" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001199107.1:c.752del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615338" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605021" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616044" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614617" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BGR 3.2024 hg19</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Disease" MappingType="XRef" MappingValue="605021" MappingRef="OMIM">
        <MedGen CUI="C0917800" Name="Familial infantile myoclonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Disease" MappingType="XRef" MappingValue="615338" MappingRef="OMIM">
        <MedGen CUI="C3809173" Name="Developmental and epileptic encephalopathy, 16" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4259180" TraitType="Disease" MappingType="XRef" MappingValue="C3463992" MappingRef="MedGen">
        <MedGen CUI="C3463992" Name="Developmental and epileptic encephalopathy, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000118" MappingRef="HP">
        <MedGen CUI="C4021819" Name="Phenotypic abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Disease" MappingType="XRef" MappingValue="614617" MappingRef="OMIM">
        <MedGen CUI="C2829265" Name="Autosomal recessive nonsyndromic hearing loss 86" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4259180" TraitType="Disease" MappingType="XRef" MappingValue="CN220131" MappingRef="MedGen">
        <MedGen CUI="C3892048" Name="Autosomal dominant nonsyndromic hearing loss 65" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Disease" MappingType="XRef" MappingValue="616044" MappingRef="OMIM">
        <MedGen CUI="C3892048" Name="Autosomal dominant nonsyndromic hearing loss 65" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982908" TraitType="Disease" MappingType="XRef" MappingValue="220500" MappingRef="OMIM">
        <MedGen CUI="C0795934" Name="DOORS syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4259180" TraitType="Finding" MappingType="XRef" MappingValue="C3809181" MappingRef="MedGen">
        <MedGen CUI="CN236805" Name="Caused by mutation in the TBC1 domain family, member 24" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

